To answer this question, we tested IHC accuracy in the membrane/cytoplasmic marker EGFR in lung cancer (N=35 participants, each scoring 10 images) and for the nuclear marker p53 in bladder cancer (N=45 participants, each scoring 10 images). The gene discussed is TP53; the disease is urinary bladder carcinoma.